Magazine article Black Issues in Higher Education

Hampton's Pharmacy School Receives $2 Million to Study Ecstasy

Magazine article Black Issues in Higher Education

Hampton's Pharmacy School Receives $2 Million to Study Ecstasy

Article excerpt

HAMPTON, VA.

The Department of Pharmaceutical Sciences in the Hampton University School of Pharmacy recently received a $2.1 million award from the National Institute on Drug Abuse at National Institutes of Health to study the causes of the symptoms associated with the drug MDMA (Ecstasy).

MDMA is a synthetic, psychoactive drug with both stimulant and hallucinogenic properties. Street names for MDMA include Ecstasy, Adam, XTC, hug, beans and love drug.

The grant, part of the Minority Institutions' Drug Abuse Research Program, is a five-year project directed by Dr. Hugh M. McLean and assistant program director Dr. Simone Heyliger.

"MDMA is rapidly becoming a problem of monumental proportions," McLean says. "Its current popularity is inextricably linked to its use at all night parties called raves, at which the drug is taken to produce euphoria, energy and a desire to socialize. Although the drug has developed the reputation as a safe drug, several studies in rats and humans have established unequivocally that MDMA induces a myriad of deleterious effects, including a variety of psychopathological states. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.